Search
Search Results
##search.searchResults.foundPlural##
-
Can Polycythemia Vera evolve from Acute Myeloid Leukemia? A Case Report Showing a Simultaneous Minor JAK2 V617F Mutated Clone, De novo polycythemia vera following AML remission
1692PDF: 782HTML: 264 -
COEXISTENCE OF MULTIPLE GENE VARIANTS IN SOME PATIENTS WITH ERYTHROCYTOSES Multiple gene variants in erythrocytosis
867PDF: 1245HTML: 136 -
Calreticulin mutation survey by high resolution melting method associated with unique presentations in essential thrombocythemic patients CALR mutation survey by HRM in ET patients
1281PDF: 741HTML: 437 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2169PDF: 1721HTML: 383 -
THE Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. Dual Myeloid Disorder Treated with Two Drug Association
1086PDF: 1169HTML: 98 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1199PDF: 767HTML: 1372Figure 1: 194Figure 2: 196 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3067PDF: 918HTML: 2042 -
-
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3264PDF: 1462HTML: 5953Fig1-Ag-Pil: 234Ag-Pil Fig.2: 237 -
SPLANCHNIC VEIN THROMBOSIS IN THE MEDITERRANEAN AREA IN CHILDREN
2204PDF: 929HTML: 1655 -
CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH
1701PDF: 747HTML: 2347 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1402HTML: 475PDF: 834 -
Diagnosis of del(5q) MDS, 14 years after JAK-2 positive PV appearance: complete remission of both diseases with lenalidomide monotherapy
2816PDF: 772HTML: 1279Blood Count trend before and during lenalidomide treatment: 175Light micrograph of bone marrow biopsy of a patient with PV and 5q deletion: 198 -
Acute Cytomegalovirus infection as a cause of venous thromboembolism
1589PDF: 852HTML: 1039Picture 1: 173 -
-
-
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9157PDF: 6102HTML: 87969Fig.1b: 191Fig.1c: 197Fig.2a: 185Fig.2b: 181Fig.4: 194Fig.2c: 190Fig.3: 189Tab.1: 239Tab.2: 214Tab.3: 196Tab.4: 230Fig1a: 194 -
-
Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF
1786PDF: 582HTML: 288 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1578PDF: 1042HTML: 238 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3815PDF: 1682HTML: 11629Figures Haase: 207 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1265PDF: 1016HTML: 225 -
Idiopathic pulmonary embolism in a case of severe family ANKRD26 thrombocytopenia
2162PDF: 840HTML: 932Patient’s family tree: 173 -
-
THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
4154PDF: 1974HTML: 1774 -
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells
976PDF: 1220HTML: 115
1 - 46 of 46 items







